Table 3.
Associations between Cardiometabolic Risk Factors and Echocardiographic Left Ventricular Hypertrophy in Men.
| LVM/height2.7 ≥ 46 g/m2.7 | ||||||
|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | ||||
| OR (95% CI) | p-value | OR (95% CI) | p-value | OR (95% CI) | p-value | |
| BP ≥ 130/85 mmHg | 4.24 (2.90–6.21) | < 0.01 | 4.15 (2.83–6.08) | < 0.01 | 2.83 (1.89–4.23) | < 0.01 |
| Total cholesterol ≥ 200 mg/dl | 1.10 (0.71–1.69) | 0.67 | 1.10 (0.71–1.70) | 0.67 | 1.00 (0.64–1.55) | 0.98 |
| HDL-C < 40 mg/dl | 1.42 (0.92–2.19) | 0.11 | 1.36 (0.88–2.10) | 0.16 | 0.96 (0.61–1.52) | 0.86 |
| Serum triglycerides ≥ 150 mg/dl | 1.82 (1.20–2.75) | < 0.01 | 1.78 (1.18–2.70) | < 0.01 | 1.38 (0.90–2.11) | 0.14 |
| Fasting glucose ≥ 100 mg/dl | 1.13 (0.73–1.76) | 0.58 | 1.13 (0.73–1.76) | 0.58 | 0.90 (0.57–1.43) | 0.66 |
| Serum uric acid ≥ 7.0 mg/dl | 2.32 (1.59–3.40) | < 0.01 | 2.28 (1.56–3.34) | < 0.01 | 1.67 (1.12–2.48) | 0.01 |
| Waist circumference ≥ 90 mg/dl | 3.53 (2.39–5.22) | < 0.01 | 3.38 (2.28–5.02) | < 0.01 | 1.22 (0.71–2.10) | 0.46 |
| Metabolic syndrome | 3.11 (2.04–4.73) | < 0.01 | 2.96 (1.94–4.52) | < 0.01 | 1.58 (0.99–2.50) | 0.05 |
Multiple logistic regressions were used to determine the association of cardiometabolic risk factors with echocardiographic left ventricular hypertrophy.
Model 1 adjusted for age, BP ≥ 130/85 mmHg, total cholesterol ≥ 200 mg/dl, HDL-C < 40 mg/dl, serum triglycerides ≥ 150 mg/dl, fasting glucose ≥ 100 mg/dl, serum uric acid ≥ 7.0 mg/dl, waist circumference ≥ 90 mg/dl, metabolic syndrome status, cigarette smoking status and alcohol intake status.
Model 2 adjusted for the covariates in model 1 and 3000-m running time.
Model 3 adjusted for the covariates in model 2 and body weight.
BP Blood pressure, HDL-C High-density lipoprotein cholesterol, LVM Left ventricular mass.